You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CEFTRIAXONE SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ceftriaxone Sodium patents expire, and when can generic versions of Ceftriaxone Sodium launch?

Ceftriaxone Sodium is a drug marketed by Anda Repository and Hikma and is included in two NDAs.

The generic ingredient in CEFTRIAXONE SODIUM is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ceftriaxone Sodium

A generic version of CEFTRIAXONE SODIUM was approved as ceftriaxone sodium by ANDA REPOSITORY on January 20th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CEFTRIAXONE SODIUM?
  • What are the global sales for CEFTRIAXONE SODIUM?
  • What is Average Wholesale Price for CEFTRIAXONE SODIUM?
Drug patent expirations by year for CEFTRIAXONE SODIUM
Recent Clinical Trials for CEFTRIAXONE SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of DuhokN/A
Ahmad ZiaPhase 3
Nadeem IqbalPhase 3

See all CEFTRIAXONE SODIUM clinical trials

Pharmacology for CEFTRIAXONE SODIUM
Medical Subject Heading (MeSH) Categories for CEFTRIAXONE SODIUM

US Patents and Regulatory Information for CEFTRIAXONE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository CEFTRIAXONE SODIUM ceftriaxone sodium INJECTABLE;INJECTION 091117-001 Jan 20, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma CEFTRIAXONE SODIUM ceftriaxone sodium INJECTABLE;INJECTION 090701-001 Oct 4, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.